A B S T R A C T Diabetes stimulates the functional activity of the intestinal brush border membrane with enhancement of both hydrolytic enzyme activity and membrane transport systems. To determine the mechanism of this effect, we studied the effects of streptozotocin diabetes on the metabolism of one membrane protein, sucrase-isomaltase, which increases its activity in diabetes. The protein was purified and an antiserum prepared. Sucrase-isomaltase from control and diabetic rats was immunologically identical as shown by Ouchterlony double-diffusion analysis of papainsolubilized mucosal proteins. The increase in sucrase enzyme activity in diabetic animals (31.0±1.4 U SEM 5 days after streptozotocin vs. 13.1±1.0 in controls) was the consequence of increased enzyme protein and not an alteration in catalytic efficiency as demonstrated by quantitative immunoprecipitin reactions.
was the consequence of increased enzyme protein and not an alteration in catalytic efficiency as demonstrated by quantitative immunoprecipitin reactions.
To account for increased sucrase-isomaltase protein in diabetes we studied papain-solubilized mucosal proteins labeled by injection of [14C]carbonate and
[14C]leucine and analyzed incorporation into sucraseisomaltase protein (anti-serum precipitable) and total protein (trichloroacetic acid precipitable). We found that diabetes did not affect the decay of labeled total protein, but prolonged the decay of labeled sucraseisomaltase. t4 of sucrase-isomaltase was 4.4 h in control animals after [14C]carbonate injection and 8.8 and 10.2 h, respectively, 2 and 5 days after induction of streptozotocin diabetes. We obtained similar results in experiments with [14C]leucine with diabetes increasing t4 from 6 to 13.6 h. Diabetes did not appear to increase the rate of addition of sucrase-isomaltase to the brush border membrane, since it did not affect the 10-and 60-min incorporations of isotope into sucrase-
INTRODUCTION
Insulin deficiency stimulates the functional activity of the brush border membrane of the intestinal absorptive cell. For example, experimental diabetes has been reported to increase the enzymatic activity of many brush border hydrolases including the disaccharidases (1) (2) (3) (4) and to stimulate a number of transport systems believed to reside in this membrane (5) (6) (7) (8) (9) (10) . Diabetes mellitus in man has also been associated with increased intestinal disaccharidase activity (11, 12) and enhanced glucose absorption (13) , although negative studies in man have also been reported (14, 15) perhaps because of differing severity of the disease and effects of treatrnent. We have examined the effects of experimental diabetes on the metabolism of a representative brush border membrane enzyme, sucrase, to obtain some insight into the mechanism of the increased function of this membrane in diabetes. Our results indicate that increased enzyme activity is the consequence of an increase in sucrase-isomaltase protein which develops because of a decrease in its rate of degradation. 70 mg/kg, in 0.05 M sodium citrate buffer, pH 4.5, after an overnight fast. The animals were housed in metabolic cages, and 24 -h urine collections were tested for glucose (Clinistix, Ames Co., Div. of Miles Lab., Inc., Elkhart, Ind.). Only those rats with heavy glucosuria (500 mg/100 ml or more) which corresponds to a blood glucose at the time of sacrifice of 300-500 mg/100 ml (7) were used for study. Control animals were similarly fasted for 24 h, but not injected. After fasting, all rats were allowed free access to standard laboratory food and water. 2 or 5 days after injection of streptozotocin, diabetic and control rats were given either 20 ,Ci of ['4C]leucine (L-[1-_4C]leucine, sp act > 50 mCi/ mmol, New England Nuclear, Boston, Mass.) or 300 IuCi [I4C]sodium carbonate (sp act 2-10 mCi/mmol, New England Nuclear) by tail vein between 7 and 8 a.m. after an overnight fast. Thereafter they were allowed free access to water but food was withheld. Animals were sacrificed at intervals to 24 h. The small intestine from the ligament of Treitz to the cecum was removed, flushed with ice-cold saline, everted, rinsed with saline, and scraped with a glass slide over ice to remove the mucosa. Mucosa from each rat was homogenized in 0.1 M potassium phosphate buffer, pH 7.4 (5 ml/g of mucosa) over ice for 10 and then 15 s with a Polytron homogenizer at setting no. 4 (Brinkmann Instruments, Inc., Westbury, N. Y.). After addition of 0.2 mg/ml papain and 0.2 mg/ml cysteine (Sigma Chemical Co., St. Louis, Mo.) the homogenates were incubated at 37°C for 60 min and then centrifuged for 60 min at 105,000g at 4°C. Supernatant fractions were then dialyzed against 0.1 M potassium phosphate buffer, pH 7.4, overnight in the cold. Dialyzed supernatant fractions will be subsequently referred to as papain supernates.
The technique of Siekevitz (16) was used to isolate total protein in papain supematant fractions. In duplicate runs, protein was precipitated with trichloroacetic acid after which nucleic acid was removed with hot trichloroacetic acid and lipid with alcohol-ether-chloroform and ether. The final air-dried residue was dissolved in 300 ,ul of 0.3 N sodium hydroxide for determination of protein and radioactivity.
Sucrase-isomaltase protein was determined using the following technique. Sufficient antiserum to precipitate all enzyme activity was added to three aliquots of each papain supernate in centrifuge tubes. In practice, 0.02 ml of antiserum was added to aliquots containing 0.47 U of sucrase activity made up to identical volumes with isotonic saline. The tubes were then held at 4°C for 2 days and centrifuged at 1,000 g for 15 min at 40C. The pellet was washed three times with isotonic saline and dissolved in 100 ,ul of 0.3 N sodium hydroxide. Solubilized pellets from two tubes were assayed separately for radioactivity, and the pellet from the third tube was used to measure protein (26) . To ensure that all enzyme had been precipitated, the supernate from one of the three tubes was assayed for sucrase activity, but in no case was enzyme activity found. To correct for nonspecific precipitation (17) , the supernate was removed from one tube, and to the supernate was added nonradioactive papain supernate containing 0.47 U of sucrase. Immunoprecipitation was again performed and the precipitate counted. This precipitate contained no labeled enzyme but did contain whatever radioactivity was trapped in the antigen-antibody complex. Disintegrations per minute in this pellet was subtracted from mean disintegrations per minute of the two initial precipitates to obtain the disintegrations per minute of sucrase-isomaltase. Addition of control, nonimmune serum to papain supernates resulted in no precipitation.
Total radioactivity of papain-supematant protein and sucrase-isomaltase protein was plotted against time on semilogarithmic paper for calculation of half-lives. Differences in the slopes of the lines were assessed by the method given by Goldstein (18) .
Purification of sucrase-isomaltase. 30 Sprague-Dawley rats were sacrificed, and the intestinal mucosa was removed by scraping. Brush borders were prepared by the method of Forstner et al. (19) and added to sufficient 0.05 M potassium phosphate buffer, pH 7.2, to yield a protein concentration of 4 mg/ml. After sonication with a Bronwill probe sonicator (VWR Scientific Div., UNIVAR, San Francisco, Calif.) for 30 s at the lowest setting (20) , 0.2 mg/ml papain and 2.0 mg/ml cysteine were added, and the mixture was incubated at 37°C for 60 min. The mixture was centrifuged at 105,000 g for 60 min at 4°C, and the supemate was treated as described by Kolinska and Kraml (21) . Briefly, the supernate was precipitated with ethanol at -15°C, and the precipitate was dissolved in 0.01 M potassium phosphate buffer, pH 7.4. After centrifugation at 105,000 g for 60 min at 4°C, the supernate was applied to a 5 x 100-cm column packed with Sephadex G-200 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) and eluted with potassium phosphate buffer. The sucrase-containing fractions were combined and applied to a DEAE-cellulose column equilibrated with 0.01 M potassium phosphate buffer, pH 7.4. After a wash with 500 ml of this buffer, a shallow chloride gradient was applied to release sucraseisomaltase. The protein was concentrated by filtration using an Amicon PM 10 filter (Amicon Corp., Lexington, Mass.) to a protein concentration of 0.81 mg/ml and stored at -20°C until use.
To assess homogeneity of purified sucrase-isomaltase, 12 ,ug of protein was subjected to acrylamide gel electrophoresis (22) in 7.5% acrylamide in two pH systems: an anionic gel system at pH 9.56 with a 3.3% spacer gel and a cationic gel system at pH 4.3 with a 2.5% spacer gel. 5 x 120-mm tubes were used with 2-3 mA per tube until a bromphenol blue tracking dye migrated within 3-5 mm from the end. Gels were stained with Coomassie Blue (23) .
Preparation of antiserum. 0.5 mg of purified sucraseisomaltase protein was mixed with Freund's complete adjuvant in a 1:1 volume ratio and injected subcutaneously into a rabbit. The injection was repeated 28 days later; 1 wk thereafter the rabbit was bled from an ear vein. Serum was stored at -70°C until use. Control antiserum was obtained from rabbits which received only Freund's adjuvant. Double diffusion in agar gel was carried out as described by Ouchterlony (24) and quantitative precipitin reactions as described by Kabat and Mayer (25) .
Chemical, enzymatic, and radioactivity determinations. Protein was determined by the method of Lowry et al. (26) and sucrase activity by the method of Dahlqvist (27) . Radioactivity was measured by mixing up to 0.2-ml aliquots with 15 ml of toluene: alcohol: Liquifluor (New England Nuclear), 1 It should also be noted that Fig. 3 (Fig. 4) Effects of diabetes on calculated synthetic rate constants. We also calculated rate constants for synthesis in control and diabetic animals using formulas described by Berlin and Schimke (29) . In controls, assuming a steady state where synthesis is equal to degradation, S = P -K, where S = the rate constant for synthesis, P = initial enzyme mass per animal, and e-KIT where K', the rate constant in diabetics, is derived from ti = (In 2)/K', PO = the original enzyme mass per rat (i.e., mean mass in controls), P = mean enzyme mass per rat after 5 days of diabetes, and T = time (120 h). Calculated rate constants for synthesis for controls and diabetics were the same (0.113 mg/h in controls and 0.110 in diabetics). DISCUSSION Experimental diabetes is associated with a variety of functional changes in the intestinal brush border membrane. There is an increase in the total and specific enzymatic activity of several membrane-bound hydrolases including sucrase, maltase, lactase, trehalase, leucylnaphthylamidase, and alkaline phosphatase (1-4) . In addition, enhancement of active Methods were the same as given for Fig. 4 . Mean±SEM from three animals are given for each time point. The difference between diabetic and control slopes was significant, P < 0.02. t4 for sucrase-isomaltase was 6.0 h in controls and 13.6 h in diabetics.
transport mechanisms for monosaccharides (5-7), amino acids (7), sodium (8) , and bile acids (9) has been reported; that this enhancement is also the result of a membrane effect is suggested by the recent observation of increased glucose transport by isolated brush border membrane vesicles prepared from diabetic animals (10) . We sought to investigate the mechanism of these changes by studying the metabolism in vivo of one representative protein, sucraseisomaltase.
Since enhancement of activity of an enzyme may be the consequence of either an increase in the amount of enzyme protein present or an increase in the (32) . This method may be the best technique, therefore, for studying degradation rates of proteins (33) .
We gave considerable thought to the route of administration of isotope. Alpers has shown that intravenous injection of precursor amino acid labels proteins from crypt cells more readily than proteins from villus cells and found the converse after intraluminal injection; this suggests that studies of metabolism of villus cell proteins, such as sucrase-isomaltase, might better be done with intraluminal injection of precursor (34) . We decided upon intravenous administration, however, for two reasons. First, we wished to use the [14C]carbonate method where, presumably, most labeled amino acid would arrive via the vascular system anyway. Second, we wanted to use the entire jejunum and ileum, which could be labeled conveniently in [14C]leucine studies by intravenous injection, to provide enough papain supernate to allow studies of individual animals and to provide a more reproducible segment length.
Our studies confirm several previous observations concerning protein metabolism in normal intestine. After injection of isotope there was a lag of 6-8 h before maximal labeling of papain supernatant proteins and sucrase-isomaltase (Table II) (32) . Diabetes resulted in a marked decrease in the rate of degradation of sucrase-isomaltase in studies using either carbonate or leucine. This was true even 2 days after administration of streptozotocin suggesting that decreased turnover of sucrase-isomaltase is an early event in the diabetic animal. Could decreased decay of labeled sucrase-isomaltase in diabetes be artifactual and not a reflection of true degradation of the protein? The major problems with pulse-labeling methods of determining protein degradation have been: (a) reutilization of the isotope and (b) impurity of the isolated sample with radioactivity measured in a minor protein contaminent rather than in the protein of interest (31) . We found that decay in the protein was prolonged, not only in studies using [14C]leucine as the precursor, but also in our [14C] carbonate studies where utilization is minimized. This makes it very unlikely that our results were the consequence of increased reutilization in the diabetic animal. The results of our agar double-diffusion and immunoprecipitin studies make it also very unlikely that we were measuring the radioactivity of a contaminent. Thus, we believe that decreased degradation of the enzyme in diabetes is a real phenomenon.
The possibility that our findings were the consequence of a decrease in absorptive cell turnover should be considered, especially since decreased cell turnover has been reported in two situations which have some similarity to experimental diabetes: partial starvation and repeated glucagon administration (37) . Intestinal epithelial cell turnover in diabetes, however, has been reported to be normal or increased, but not decreased (38) . More importantly, we found an effect on turnover of a single protein in papain supernatant fractions, but not on turnover of proteins in general. If the effect were primarily on cell turnover, degradation of total protein would be expected to be prolonged. Thus, it is very unlikely that prolonged degradation of sucrase-isomaltase is secondary to a primary effect on cell turnover.
We considered the possibility that diabetes also increased the rate of synthesis of sucrase-isomaltase. Alpers and Kinzie have summarized the difficulties of determining the true synthetic rates of intestinal proteins (33) . Among these problems are the heterogeneous cell population of the intestine, the difficulty of labeling all villus cells, the likelihood that experimental manipulations, such as induction of diabetes, would change the amino acid pool size, and the lag time before maximal labeling of brush border proteins. We therefore attempted to measure a relative synthetic rate of sucrase-isomaltase, relating 10-and 60-min incorporations into that protein to incorporation into total papain supernatant proteins. As shown in Table III , diabetes did not appear to affect relative synthesis of sucrase-isomaltase. It should be stressed that this relative synthetic rate probably bears little relation to the true synthetic rate of the protein, but the studies do suggest that addition of this protein to the brush border membrane does not occur faster than addition of other papain-removable proteins in diabetes. In addition, diabetes did not affect the synthetic rate constant for sucrase as calculated from enzyme mass and t1. Thus, diabetes does not appear to affect the rate of incorporation of sucrase-isomaltase into the brush border membrane.
The finding of an apparently normal synthetic rate with a decreased degradative rate suggests that enzyme activity will progressively increase with time. However, at some point it is likely that the synthetic rate will fall, otherwise, sucrase-isomaltase would continue to increase indefinitely. The available data are consistent with this suggestion: sucrase activity progressively increases for at least the first 5 days of diabetes and appears to reach a new steady state sometime during the 2nd wk (4), presumably because a fall in synthetic rate.
Since the effects of experimental diabetes on brush border membrane functional proteins differ so strikingly both from the reduction in general protein synthesis found in skeletal and cardiac muscle (39) and from the increased protein catabolism suggested in liver (40) , the possibility should be considered that the intestinal effects are not the consequence of the diabetes, but of an additional effect of streptozotocin or of an alteration in food consumption in the streptozotocin-injected animals. This possibility seems unlikely. The intestinal effects are prevented or markedly diminished by insulin therapy (3, 4, 7) , suggesting that they are in fact the result of insulin deficiency. They also occur in segments of intestine completely excluded from luminal continuity (41), thus they cannot be the direct consequence of altered food consumption. Finally, they do not occur in control animals pair-fed with diabetics (1, 7). We cannot completely exclude the possibility, however, that a more subtle alteration in patterns of food consumption might be important, perhaps by changing blood levels of hormones.
We can only speculate on the cause of altered degradation of sucrase-isomaltase in diabetes. Although altered degradation rates have frequently been found responsible for changes in enzyme activity in other mammalian tissues (31) , mechanisms of altered enzyme activity in the intestine have rarely been studied. Alpers and Tedesco, however, have recently reported that enhanced activity of several brush border enzymes in rats subjected to subtotal pancreatectomy is the consequence of decreased degradative rates (42) , probably because of diminished intraluminal proteases. Thus alterations in degradation may turn out to be an important control mechanism for intestinal enzyme levels. Whether our findings in diabetes are the result of enhanced resistance to degradation or inhibition of the mechanism of degradation is unknown. Since sucrase-isomaltase contains a large quantity of carbohydrate (43), it is tempting to speculate that some alteration in the carbohydrate moieties of the protein might increase its resistance to degradation, especially since changes in carbohydrate composition of other glycoproteins have been reported in diabetes (44) . Whatever the basis for decreased degradation of sucrase-isomaltase, it is likely that stimulation of general brush border function in diabetes occurs through a similar mechanism.
